| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 6 | |
| #2 | Singapore | 6 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Canada | 4 | |
| #5 | Israel | 4 | |
| #6 | Republic of Korea | 3 | |
| #7 | United States | 3 | |
| #8 | China | 2 | |
| #9 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks | |
| #5 | Environmental technology | |
| #6 | Organic fine chemistry | |
| #7 | Basic materials chemistry | |
| #8 | Machines |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bolinger Cheryl G | 18 |
| #2 | Kurella Vinodhbabu | 17 |
| #3 | Metenou Simon | 17 |
| #4 | Yarlagadda Ramya | 13 |
| #5 | Shah Rutul R | 13 |
| #6 | Prabakaran Ponraj | 13 |
| #7 | Brough Douglas E | 13 |
| #8 | Ding Kuan-Fu | 11 |
| #9 | Chen Changhung | 8 |
| #10 | Sabzevari Helen | 8 |
| Publication | Filing date | Title |
|---|---|---|
| AU2019301147A1 | ROR-1 specific chimeric antigen receptors and uses thereof | |
| SG11202012203PA | In vivo controlled combination therapy for treatment of cancer | |
| AU2019282620A1 | MUC16 specific chimeric antigen receptors and uses thereof | |
| AU2019231654A1 | Human papillomavirus vaccines and uses of the same |